Pfizer-BioNTech COVID-19 vaccine approved for children ages 12 to 15

By: Alyssa Wilson

The Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine to be used in children as young as 12 on an emergency use basis.  

Acting FDA Commissioner Dr. Janet Woodwock said the decision by the organization can get the United States closer to a return to normal and that they took the review seriously, CNBC reported.  

A clinical trial involving more than 2,000 12-to-15-year-olds revealed that the vaccine was well tolerated. It had an efficacy rate of 100% within the age group.  

RELATED: Pfizer, BioNTech COVID-19 vaccine 100% effective in children 12 – 15  

On Wednesday, the CDC endorsed the safety and effectiveness of the Pfizer-BioNTech vaccine for the age group. 

RELATED: Pfizer, BioNTech testing COVID-19 vaccine in children under 12 

Pfizer and BioNTech also began testing the vaccine on children between the ages of 6 months and 11 years old.  

Latest in News

Melvin Van Peebles


Melvin Van Peebles Dead at Age 89


Women Serving Life Sentences Without Parole Increased Over Past Decade


Group of Current and Former Black Women Cops Sue DC Police


Joyce Beatty Initiates Rosa Parks National Holiday


LGBTQ Veterans Discharged for Sexual Orientation to Receive VA Benefits


Search Continues for Jelani Day Who’s Been Missing Since August


George Holliday, Who Filmed Rodney King Beating, Dies From COVID-19

Denzel Washington


Denzel Washington Stars in ‘The Tragedy of Macbeth’